Literature DB >> 9792667

Inactivation of tumor suppressor p53 by mot-2, a hsp70 family member.

R Wadhwa1, S Takano, M Robert, A Yoshida, H Nomura, R R Reddel, Y Mitsui, S C Kaul.   

Abstract

The mortalin genes, mot-1 and mot-2, are hsp70 family members that were originally cloned from normal and immortal murine cells, respectively. Their proteins differ by only two amino acid residues but exhibit different subcellular localizations, arise from two distinct genes, and have contrasting biological activities. We report here that the two proteins also differ in their interactions with the tumor suppressor protein p53. The pancytosolic mot-1 protein in normal cells did not show colocalization with p53; in contrast, nonpancytosolic mot-2 and p53 overlapped significantly in immortal cells. Transfection of mot-2 but not mot-1 resulted in the repression of p53-mediated transactivation in p53-responsive reporter assays. Inactivation of p53 by mot-2 was supported by the down-regulation of p53-responsive genes p21(WAF-1) and mdm-2 in mot-2-transfected cells only. Furthermore, NIH 3T3 cells transfected with expression plasmid encoding green fluorescent protein-tagged mot-2 but not mot-1 showed an abrogation of nuclear translocation of wild-type p53. These results demonstrate a novel mechanism of p53 inactivation by mot-2 protein.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9792667     DOI: 10.1074/jbc.273.45.29586

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  64 in total

Review 1.  Hsp70 interactions with the p53 tumour suppressor protein.

Authors:  M Zylicz; F W King; A Wawrzynow
Journal:  EMBO J       Date:  2001-09-03       Impact factor: 11.598

2.  An N-terminal region of mot-2 binds to p53 in vitro.

Authors:  S C Kaul; R R Reddel; Y Mitsui; R Wadhwa
Journal:  Neoplasia       Date:  2001 Mar-Apr       Impact factor: 5.715

Review 3.  On the brotherhood of the mitochondrial chaperones mortalin and heat shock protein 60.

Authors:  Custer C Deocaris; Sunil C Kaul; Renu Wadhwa
Journal:  Cell Stress Chaperones       Date:  2006       Impact factor: 3.667

4.  Identification and characterization of molecular interactions between glucose-regulated proteins (GRPs) mortalin/GRP75/peptide-binding protein 74 (PBP74) and GRP94.

Authors:  S Takano; R Wadhwa; Y Mitsui; S C Kaul
Journal:  Biochem J       Date:  2001-07-15       Impact factor: 3.857

5.  Mortalin is a prognostic factor of gastric cancer with normal p53 function.

Authors:  Koji Ando; Eiji Oki; Yan Zhao; Ayae Ikawa-Yoshida; Hiroyuki Kitao; Hiroshi Saeki; Yasue Kimura; Satoshi Ida; Masaru Morita; Tetsuya Kusumoto; Yoshihiko Maehara
Journal:  Gastric Cancer       Date:  2013-07-05       Impact factor: 7.370

Review 6.  Glucose-regulated proteins in cancer: molecular mechanisms and therapeutic potential.

Authors:  Amy S Lee
Journal:  Nat Rev Cancer       Date:  2014-04       Impact factor: 60.716

7.  Functional significance of point mutations in stress chaperone mortalin and their relevance to Parkinson disease.

Authors:  Renu Wadhwa; Jihoon Ryu; Hyo Min Ahn; Nishant Saxena; Anupama Chaudhary; Chae-Ok Yun; Sunil C Kaul
Journal:  J Biol Chem       Date:  2015-02-02       Impact factor: 5.157

Review 8.  An Hsp70 family chaperone, mortalin/mthsp70/PBP74/Grp75: what, when, and where?

Authors:  Renu Wadhwa; Kazunari Taira; Sunil C Kaul
Journal:  Cell Stress Chaperones       Date:  2002-07       Impact factor: 3.667

9.  Overproduction and biophysical characterization of human HSP70 proteins.

Authors:  Rebba C Boswell-Casteel; Jennifer M Johnson; Kelli D Duggan; Yuko Tsutsui; Franklin A Hays
Journal:  Protein Expr Purif       Date:  2014-09-27       Impact factor: 1.650

10.  Down-regulation of mortalin exacerbates Aβ-mediated mitochondrial fragmentation and dysfunction.

Authors:  So Jung Park; Ji Hyun Shin; Jae In Jeong; Ji Hoon Song; Yoon Kyung Jo; Eun Sung Kim; Eunjoo H Lee; Jung Jin Hwang; Eun Kyung Lee; Sun Ju Chung; Jae-Young Koh; Dong-Gyu Jo; Dong-Hyung Cho
Journal:  J Biol Chem       Date:  2013-12-09       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.